Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 139 clinical trials
Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus

Randomized, controlled, blind, single-center and non-inferiority clinical trial to compare the target lesion failure (TLF) at 12 months in patients with diabetes mellitus who underwent percutaneous coronary intervention with an Orsiro stent vs. Abluminus stent.

  • 0 views
  • 28 Jan, 2021
  • 1 location
Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

The FANTOM II trial is intended to assess safety and performance of the Fantom Bioresorbable Coronary Scaffold in native coronary arteries.

stenosis
sirolimus
ischemia
  • 21 views
  • 21 Jan, 2021
  • 20 locations
Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease

A prospective, multicenter study is preformed to evaluate the safety and efficacy of NOYA CoCr biodegradable coating sirolimus-eluting stents in treating coronary artery lesions.

arterial disease
stenosis
sirolimus
bypass graft
  • 15 views
  • 07 Nov, 2020
  • 1 location
A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions

E.V.O.L.U.T.I.O.N.: A Randomized Study to Evaluate Safety and Efficacy of the Excel Sirolimus Eluting Stent with a Biodegradable Polymer Versus Sirolimus Eluting Stent with a Non

coronary angioplasty
unstable angina
angina pectoris
ischemia
stable angina
  • 15 views
  • 07 Nov, 2020
  • 1 location
Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

To compare the clinical outcomes of dual antiplatelet therapy with aspirin and ticagrelor vs. ticagrelor monotherapy at 3 months after PCI in patients with acute coronary syndrome.

antiplatelet therapy
dapt
sirolimus
thrombosis
ticagrelor
  • 10 views
  • 22 Jan, 2021
  • 1 location
FANTOM Post Market Clinical Trial

Post Market study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold

stenosis
sirolimus
ischemia
chest pain
bypass graft
  • 7 views
  • 22 Jan, 2021
  • 1 location
Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty

The SirPAD trial is an academic, investigator-initiated, single-center, randomized, non-inferiority, open-label clinical trial investigating whether the use of sirolimus-coated balloon catheters

  • 0 views
  • 26 Jan, 2021
  • 1 location
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II

The FUTURE-II study is a confirmative clinical trial for Sirolimus Target Eluting Bioresorbable Vascular Scaffold (Firesorb) after the feasibility and safety of the device has been preliminary

exercise stress test
bypass graft
infarct
stenosis
unstable angina
  • 51 views
  • 22 Jan, 2021
  • 1 location
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation

artery disease undergoing sirolimus-eluting Orsiro stent implantation.

angiography
quantitative coronary angiography
chest pain
intravascular ultrasound
coronary artery disease
  • 3 views
  • 27 Jan, 2021
  • 8 locations
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

sirolimus -eluting stent with abluminal grooves containing a biodegradable polymer in High Bleeding Risk patients with coronary artery disease.

percutaneous coronary intervention
antiplatelet therapy
dapt
clopidogrel
aspirin
  • 1 views
  • 26 Jan, 2021
  • 1 location